특허 및 논문

바이오솔빅스에 자료실을 확인해 보세요.
bt_bb_section_bottom_section_coverage_image

BIOSOLVIX ARCHIVE특허 및 논문

Metabolome Profiling of Partial and Fully Reprogrammed Induced Pluripotent Stem Cells.

작성자
관리자
작성일
2024-02-01 13:47
조회
323
Park SJ*, Lee SA, Prasain N, Bae D, Kang H, Ha T, Kim JS, Hong KS, Mantel C, Moon SH*, Broxmeyer HE*, Lee MR*. Metabolome Profiling of Partial and Fully Reprogrammed Induced Pluripotent Stem Cells. Stem Cells Dev. 2017 Mar 27.

 

Abstract


Acquisition of proper metabolomic fate is required to convert somatic cells toward fully reprogrammed pluripotent stem cells. The majority of induced pluripotent stem cells (iPSCs) are partially reprogrammed and have a transcriptome different from that of the pluripotent stem cells. The metabolomic profile and mitochondrial metabolic functions required to achieve full reprogramming of somatic cells to iPSC status have not yet been elucidated. Clarification of the metabolites underlying reprogramming mechanisms should enable further optimization to enhance the efficiency of obtaining fully reprogrammed iPSCs. In this study, we characterized the metabolites of human fully reprogrammed iPSCs, partially reprogrammed iPSCs, and embryonic stem cells (ESCs). Using capillary electrophoresis time-of-flight mass spectrometry-based metabolomics, we found that 89% of analyzed metabolites were similarly expressed in fully reprogrammed iPSCs and human ESCs (hESCs), whereas partially reprogrammed iPSCs shared only 74% similarly expressed metabolites with hESCs. Metabolomic profiling analysis suggested that converting mitochondrial respiration to glycolytic flux is critical for reprogramming of somatic cells into fully reprogrammed iPSCs. This characterization of metabolic reprogramming in iPSCs may enable the development of new reprogramming parameters for enhancing the generation of fully reprogrammed human iPSCs


Keywords: #metabolism #metabolomics #oxidative phosphorylation #reprogramming efficiency

 

논문확인(클릭시 이동) 
전체 52
번호 제목 작성자 작성일 추천 조회
32
Dual stem cell therapy synergistically improves cardiac function and vascular regeneration following myocardial infraction.
관리자 | 2024.02.01 | 추천 0 | 조회 213
관리자 2024.02.01 0 213
31
Functional Equivalency in Human Somatic Cell Nuclear Transfer-Derived Endothelial Cells.
관리자 | 2024.02.01 | 추천 0 | 조회 217
관리자 2024.02.01 0 217
30
Reconstituting human cutaneous regeneration in humanized mice under endothelial cell therapy.
관리자 | 2024.02.01 | 추천 0 | 조회 271
관리자 2024.02.01 0 271
29
Safety and Optimization of Metabolic Labeling of Endothelial Progenitor Cells for Tracking
관리자 | 2024.02.01 | 추천 0 | 조회 217
관리자 2024.02.01 0 217
28
Mechanotransduction of human pluripotent stem cells cultivated on tunable cell-derived extracellular matrix.
관리자 | 2024.02.01 | 추천 0 | 조회 213
관리자 2024.02.01 0 213
27
Angiogenesis in the Transplanted Donor Graft After Living-Donor Liver Transplantation.
관리자 | 2024.02.01 | 추천 0 | 조회 260
관리자 2024.02.01 0 260
26
From Bench to Market: Preparing Human Pluripotent Stem Cells Derived Cardiomyocytes for Various Applications
관리자 | 2024.02.01 | 추천 0 | 조회 283
관리자 2024.02.01 0 283
25
Enzyme catalyzed electrostimulation of human embryonic stem cell-derived cardiomyocytes influence contractility and synchroniza
관리자 | 2024.02.01 | 추천 0 | 조회 238
관리자 2024.02.01 0 238
24
Metabolome Profiling of Partial and Fully Reprogrammed Induced Pluripotent Stem Cells.
관리자 | 2024.02.01 | 추천 0 | 조회 323
관리자 2024.02.01 0 323
23
Effect of BMP-2 Delivery Mode on Osteogenic Differentiation of Stem Cells.
관리자 | 2024.02.01 | 추천 0 | 조회 271
관리자 2024.02.01 0 271